Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

NJSPL Report: Analyzing the Use and Equity of ARPA Funds

Report Release: Analyzing the Use and Equity of ARPA Funds in NJ Local Governments and Beyond New Jersey State Policy Lab The American Rescue Plan Act’s Coronavirus State and Local Fiscal Recovery Funds (ARPA-SLFRF) represent a historic $350 billion investment to...

Dr. Grafova Presented Posters from the VSR Research

Dr. Irina Grafova recently returned from the AcademyHealth Research Meeting in Minneapolis, where she had the opportunity to present two posters from the Virtual Schwartz Rounds emotional support program for nurses, run by the New Jersey Nursing Emotional Well-being...

Heldrich Report: Analysis of NJ Life Sciences, Tech Sectors

The Heldrich Center, in conjunction with the New Jersey Economic Development Authority (NJEDA), is pleased to share a new workforce analysis of the life sciences and technology sectors in New Jersey, with a particular emphasis on the sectors’ intersection with...

Restrepo-Mieth Researches Tree Inventories in Galápagos, Ecuador

Who wants a tree inventory and why? The politics of inventorying urban forestry in Galápagos, Ecuador Abstract Trees make significant contributions to the urban experience by providing ecosystem services and aesthetic value. Considering these contributions, cities are...

NJSPL: Georeferencing Historical Maps for Geospatial Analysis

New Jersey State Policy Lab, Jonathan DeLura Our project to create a dataset of historical water bodies in New Jersey began by finding maps of historical water bodies. Two atlases were used to locate historical water bodies in New Jersey. The first was Atlas of the...